INTRODUCTION

Understanding the relationship between opioid treatment for acute pain and subsequent long-term use is necessary to inform clinical decisions on pain treatment. Previous research has described long-term opioid use after treatment for acute pain in postoperative and fragility fracture treatment.1,2, 3 We carefully examined the association between forearm and lower leg fractures in 2011 and opioid prescription in 2011–2014 among disabled Medicare beneficiaries who did not have opioid prescriptions in 2010. We focused on forearm and lower leg fractures because these injuries to major long bones not directly connected to the torso have limited long-term health consequences and are less likely to cause health complications.

METHODS

We utilized the complete files of the 2010–2014 Medicare claims data from the Centers for Medicare and Medicaid Services (CMS). Starting with all Medicare beneficiaries under the age of 65 in 2010 who entered Medicare through the Social Security Disability Insurance program for the medically disabled, we selected individuals covered continuously for 60 months in Parts A, B, and D from 2010 to 2014. Opioid use was defined as any kind of opioid prescription identified from the Centers for Disease Control and Prevention’s (CDC) compilation of opioid formulations, based on the National Drug Code (NDC) classification system.4 We selected opioid-naïve patients (those without any opioid prescription records in 2010). We excluded beneficiaries enrolled in any managed care programs that did not report detailed claims data to CMS and individuals with records of cancer treatment, palliative care, or end-of-life care.

The study population comprised three groups: group 1—those with forearm fractures (ICD9-CM diagnosis code 813, fracture of radius and ulna) in 2011 but no other fracture record (800–829) during the period 2010–2014; group 2—those with lower leg fracture (823, fracture of tibia and fibula) in 2011 but no other fracture record; and group 3—those without any fracture record.

We conducted separate linear regressions of the probability of opioid prescription in 2011–2014 after forearm and leg fractures in 2011, controlling for various demographic and health status variables: age, gender, race/ethnicity, income, county of residence, and 2010 health status (15 conditions from the Charlson comorbidity index).

RESULTS

Group 1 included 1465 individuals, group 2 included 758, and group 3 included 957,856. The average ages for groups 1, 2, and 3 were 53.7, 53.2, and 52.4 years, respectively, and men accounted for 53.9%, 46.2%, and 42.3% of individuals in the three study groups.

In 2011, the percentage of individuals with recorded opioid prescriptions varied by group: group, 1 63.3%; group 2, 58.6%, and group 3, 17.5% (Fig. 1). After 2011, the percentages in groups 1 and 2 differed from that in group 3 by around 7%. For example, in 2014, 26.7% of group 1 and 26.4% of group 2 recorded opioid prescriptions, in contrast to 19.4% in group 3.

Figure 1
figure 1

Proportion of Medicare beneficiaries with an opioid prescription by fracture status, United States 2011–2014.

Differences among the three groups in those who had continuous opioid records from 2011 to 2014 can explain the almost parallel gaps in Figure 1. Indeed, 9.08% of group 1 and 10.16% of group 2 had opioid prescriptions for 4 consecutive years, compared with 3.56% for group 3. Long-term opioid users (with 6 or more opioid prescriptions in 2014) accounted for 47.37, 48.05, and 48.44%, respectively.

A forearm fracture in 2011 increased the chance of an opioid prescription in 2014 by 5.5%, and a lower leg fracture increased the chance by 6.1% (Table 1), after controlling for other factors. Descriptive and linear regression results pointed to similar findings: a fracture in 2011 increased the chance of an opioid prescription in 2014 by 5–8 percentage points.

Table 1 Linear Least Squares (LLS) Regression Results for 2011 Fracture and 2011–2014 Opioid Prescription, Medicare Beneficiaries (USA)

DISCUSSION

More than half of opioid-naïve patients with forearm or lower leg fractures in 2011 received opioid prescriptions that year. Over the next 3 years, these patients remained significantly more likely to have opioid prescriptions than those without fractures, which could not be explained by demographic or non-fracture health status. The analysis did not precisely capture the timing of opioid utilizations after the fracture, and the results cannot be generalized beyond a medically disabled population. Nonetheless, this paper provides evidence that over one-quarter of formerly opioid-naïve patients were prescribed opioids sometime in the 3 years after fracture. The persistence of opioid prescribing suggests a need for more effective post-fracture pain management that follows evidence-based opioid prescribing guidelines.5